Prostate Cancer Nomograms: An Update

European Urology

Volumn 50, Issue 5, 2006, Pages 914-926

  Chun, Felix K H ^a,b   Karakiewicz, Pierre I ^a   Briganti, Alberto ^a,d   Gallina, Andrea ^a,d   Kattan, Michael W ^c   Montorsi, Francesco ^d   Huland, Hartwig ^b   Graefen, Markus ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF HAMBURG   (Germany)

^c LERNER RESEARCH INSTITUTE   (United States)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Nomogram; Outcome; Prediction tools; Prognostics; Prostate cancer; Review

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ACCURACY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DESCRIPTIVE RESEARCH; HUMAN; METASTASIS; NOMOGRAM; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; REVIEW; VALIDATION STUDY;

BIOPSY; CALIBRATION; HUMANS; LIFE EXPECTANCY; MALE; NOMOGRAMS; PROSTATIC NEOPLASMS; RECURRENCE; SURVIVAL RATE;

EID: 33749249942     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.07.042     Document Type: Review

References (50)

1. Ross P.L., Scardino P.T., and Kattan M.W. A catalog of prostate cancer nomograms. J Urol 165 (2001) 1562-1568
2. Kattan M.W., Eastham J.A., Stapleton A.M., Wheeler T.M., and Scardino P.T. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90 (1998) 766-771
3. Stephenson A.J., Scardino P.T., Eastham J.A., et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98 (2006) 715-717
4. Kattan M.W., Wheeler T.M., and Scardino P.T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17 (1999) 1499-1507
5. Stephenson A.J., Scardino P.T., Eastham J.A., et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23 (2005) 7005-7012
6. Snow P.B., Smith D.S., and Catalona W.J. Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J Urol 152 (1994) 1923-1926
7. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 (1997) 1445-1451
8. Conrad S., Graefen M., Pichlmeier U., et al. Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma. J Urol 167 (2002) 521-525
9. Graefen M., Haese A., Pichlmeier U., et al. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol 165 (2001) 857-863
10. Eastham J.A., May R., Robertson J.L., Sartor O., and Kattan M.W. Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL. Urology 54 (1999) 709-713
11. Garzotto M., Hudson R.G., Peters L., et al. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL. Cancer 98 (2003) 1417-1422
12. Karakiewicz P.I., Benayoun S., Kattan M.W., et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 173 (2005) 1930-1934
13. Stephan C., Cammann H., Semjonow A., et al. Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies. Clin Chem 48 (2002) 1279-1287
14. Lopez-Corona E., Ohori M., Scardino P.T., Reuter V.E., Gonen M., and Kattan M.W. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J Urol 170 (2003) 1184-1188
15. Yanke B.V., Gonen M., Scardino P.T., and Kattan M.W. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol 173 (2005) 421-424
16. Walz J., Graefen M., Chun F.K., et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 50 (2006) 498-505
17. Kattan M.W., Eastham J.A., Wheeler T.M., et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 170 (2003) 1792-1797
18. Chun F.K., Steuber T., Erbersdobler A., et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 49 (2006) 820-826
19. Chun F.K.H., Briganti A., Shariat S.F., et al. Significant upgrading affects one in three men diagnosed with prostate cancer-predictive nomogram and internal validation. BJU Int 98 (2006) 329-334
20. Ohori M., Kattan M.W., Koh H., et al. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urol 171 (2004) 1844-1849
21. Steuber T., Graefen M., Haese A., et al. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. J Urol 175 (2006) 939-944
22. Koh H., Kattan M.W., Scardino P.T., et al. A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. J Urol 170 (2003) 1203-1208
23. Cagiannos I., Karakiewicz P., Eastham J.A., et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170 (2003) 1798-1803
24. Briganti A., Chun F.K., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 49 (2006) 1019-1027
25. Svatek R., Karakiewicz P.I., Shulman M., Karam J., Perrotte P., and Benaim E. Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer. Eur Urol 49 (2006) 666-674
26. Schwarzer G., Vach W., and Schumacher M. On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Stat Med 19 (2000) 541-561
27. Karakiewicz P.I., Chun F.K., Briganti A., et al. Prostate cancer nomograms are superior to neural networks. Can J Urol 13 (2006) 18-25
28. Kattan M.W. Comparison of Cox regression with other methods for determining prediction models and nomograms. J Urol 170 (2003) S6-S9
29. Kattan M.W. Nomograms. Introduction. Semin Urol Oncol 20 (2002) 79-81
30. Kattan M.W. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 95 (2003) 634-635
31. Bradley E., and Tibshirani R.J. Monographs on statistics and applied probability: an introduction to the bootstrap (1993), Chapman and Hall/CRC p. 275
32. Steyerberg E.W., Harrell Jr. F.E., Borsboom G.J., Eijkemans M.J., Vergouwe Y., and Habbema J.D. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54 (2001) 774-781
33. Graefen M., Karakiewicz P.I., Cagiannos I., et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol 20 (2002) 3206-3212
34. Greene K.L., Meng M.V., Elkin E.P., et al. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). J Urol 171 (2004) 2255-2259
35. Graefen M., Karakiewicz P.I., Cagiannos I., et al. Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol 20 (2002) 951-956
36. Bianco Jr. F.J., Kattan M.W., Scardino P.T., Powell I.J., Pontes J.E., and Wood Jr. D.P. Radical prostatectomy nomograms in black American men: accuracy and applicability. J Urol 170 (2003) 73-76
37. D'Amico A.V., Cote K., Loffredo M., Renshaw A.A., and Chen M.H. Pretreatment predictors of time to cancer specific death after prostate specific antigen failure. J Urol 169 (2003) 1320-1324
38. Dotan Z.A., Bianco Jr. F.J., Rabbani F., et al. Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. J Clin Oncol 23 (2005) 1962-1968
39. Slovin S.F., Wilton A.S., Heller G., and Scher H.I. Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy. Clin Cancer Res 11 (2005) 8669-8673
40. Cowen M.E., Halasyamani L.K., and Kattan M.W. Predicting life expectancy in men with clinically localized prostate cancer. J Urol 175 (2006) 99-103
41. Tewari A., Johnson C.C., Divine G., et al. Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 171 (2004) 1513
42. Albertsen P.C., Fryback D.G., Storer B.E., Kolon T.F., and Fine J. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 156 (1996) 127
43. Smaletz O., Scher H.I., Small E.J., et al. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol 20 (2002) 3972-3982
44. Specht M.C., Kattan M.W., Gonen M., Fey J., and Van Zee K.J. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 12 (2005) 6549
45. Ross P.L., Gerigk C., Gonen M., et al. Comparisons of nomograms and urologists' predictions in prostate cancer. Semin Urol Oncol 20 (2002) 82-88
46. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 48 (2005) 546-551
47. Kattan M.W., Potters L., Blasko J.C., et al. Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology 58 (2001) 393-399
48. Kattan M.W., Zelefsky M.J., Kupelian P.A., Scardino P.T., Fuks Z., and Leibel S.A. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol 18 (2000) 3352-3359
49. Kattan M.W., Zelefsky M.J., Kupelian P.A., et al. Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol 21 (2003) 4568-4571
50. Kattan M.W., Shariat S.F., Andrews B., et al. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer. J Clin Oncol 21 (2003) 3573-3579